Home » Newsletters » BioWorld MedTech

BioWorld MedTech

June 21, 2016

View Archived Issues

Drug resistance specter is fact of life for antibiotics

Digging for answers
(in the ground and IP)

Are we at risk of living in a post-antibiotic world?

CMS suspends lab fee do-over, adds hospital labs to fee calculation

IPRs emerge from SC challenge alive, robust

Other news to note

Financings

Product briefs

Keeping you up to date on recent developments with Cardiology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026